Literature DB >> 9588909

Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance.

Q Tao, R F Ambinder, L J Swinnen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9588909      PMCID： PMC1858597     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  13 in total

1.  Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas.

Authors:  W L Goldschmidts; K Bhatia; J F Johnson; N Akar; M I Gutiérrez; D Shibata; M Carolan; A Levine; I T Magrath
Journal:  Leukemia       Date:  1992-09       Impact factor: 11.528

2.  Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus.

Authors:  S N Li; Y S Chang; S T Liu
Journal:  Oncogene       Date:  1996-05-16       Impact factor: 9.867

3.  Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.

Authors:  B N Smir; R J Hauke; P J Bierman; T G Gross; F d'Amore; J R Anderson; T C Greiner
Journal:  Lab Invest       Date:  1996-10       Impact factor: 5.662

4.  Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue.

Authors:  Q Tao; K D Robertson; A Manns; A Hildesheim; R F Ambinder
Journal:  Blood       Date:  1998-02-15       Impact factor: 22.113

5.  Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.

Authors:  A G Scheinfeld; R G Nador; E Cesarman; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

6.  Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.

Authors:  D W Kingma; W B Weiss; E S Jaffe; S Kumar; K Frekko; M Raffeld
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

7.  Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.

Authors:  D Frank; E Cesarman; Y F Liu; R E Michler; D M Knowles
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

8.  Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene.

Authors:  W G Chen; Y Y Chen; M M Bacchi; C E Bacchi; M Alvarenga; L M Weiss
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

9.  The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.

Authors:  N Anwar; D W Kingma; A R Bloch; M Mourad; M Raffeld; J Franklin; I Magrath; N el Bolkainy; E S Jaffe
Journal:  Cancer       Date:  1995-10-01       Impact factor: 6.860

10.  The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya.

Authors:  M Weinreb; P J Day; F Niggli; E K Green; A O Nyong'o; N A Othieno-Abinya; M S Riyat; F Raafat; J R Mann
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.